The global Metered Dose Inhalers Market is expected to be valued at US$ 40,140 million by 2032, up from US$ 25,210 million in 2022, with a CAGR of 4.3% during the forecast period.With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents.
/PRNewswire/ The global radiopharmaceuticals market is expected to grow at a CAGR of 7.3% during the forecast period between 2021 and 2031.Growing research.
Radiopharmaceutical compounds have been deployed increasingly in different fields such as cardiology and neurologyRising installation of PET-CT scanner devices helps North America emerge as
/PRNewswire/ In 2021, value of the global market for atopic dermatitis drugs stood at US$ 6 Bn in 2021. The global market is anticipated to advance at a.